Dimension Therapeutics, Inc. Comprehensive Income
Dimension Therapeutics, Inc. reported Comprehensive Income of -$16.93 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2017-11-06
- Dimension Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-09-30 was -$16.93M.
- Dimension Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-06-30 was -$12.31M.
- Dimension Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-03-31 was -$13.54M.
- Dimension Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-12-31 was -$13.07M.
- Dimension Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$49.05M.
- Dimension Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2015 was -$35.06M.
- Dimension Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2014 was -$12.97M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$16.93M 10-Q · filed 2017-11-06 | -$29.23M derived: sum of 2 quarters · filed 2017-11-06 | -$42.77M 10-Q · filed 2017-11-06 | -$55.85M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | -$12.31M 10-Q · filed 2017-08-08 | -$25.85M 10-Q · filed 2017-08-08 | -$38.93M derived: sum of 3 quarters · filed 2017-08-08 | -$53.29M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-03-31 | -$13.54M 10-Q · filed 2017-05-10 | -$26.62M derived: sum of 2 quarters · filed 2017-05-10 | -$40.98M derived: sum of 3 quarters · filed 2017-11-06 | -$53.08M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-12-31 | -$13.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$27.44M derived: sum of 2 quarters · filed 2017-11-06 | -$39.54M derived: sum of 3 quarters · filed 2017-11-06 | -$49.05M 10-K · filed 2017-03-09 |
| 2016-09-30 | -$14.37M 10-Q · filed 2017-11-06 | -$26.46M derived: sum of 2 quarters · filed 2017-11-06 | -$35.98M 10-Q · filed 2017-11-06 | -$45.01M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | -$12.10M 10-Q · filed 2017-08-08 | -$21.61M 10-Q · filed 2017-08-08 | -$30.64M derived: sum of 3 quarters · filed 2017-08-08 | -$41.31M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | -$9.51M 10-Q · filed 2017-05-10 | -$18.54M derived: sum of 2 quarters · filed 2017-05-10 | -$29.21M derived: sum of 3 quarters · filed 2017-05-10 | |
| 2015-12-31 | -$9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$19.70M derived: sum of 2 quarters · filed 2017-03-09 | -$35.06M 10-K · filed 2017-03-09 | |
| 2015-09-30 | -$10.67M 10-Q · filed 2016-11-10 | -$26.03M 10-Q · filed 2016-11-10 | ||
| 2014-12-31 | -$12.97M 10-K · filed 2017-03-09 |